Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huma Q Rana

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|April 19, 2024
Germline and Somatic Fumarate Hydratase Testing in Atypical Uterine LeiomyomataLindsay M Kipnis, Katelyn M Breen, Diane R Koeller, et al.
The American Journal of Case Reports|December 28, 2020
Unexpected Pathogenic RET p.V804M Variant Leads to the Clinical Diagnosis and Management of Medullary Thyroid CarcinomaArezou A Ghazani, Katelyn M Breen, Meaghan Dwan, et al.
Preventive Medicine|November 15, 2023
Racial differences in knowledge, attitudes, and sources of information about germline cancer genetic testing in the U.S.A.: An analysis of the health information National Trends Survey SystemKhalid Y Alkhatib, Dejan K Filipas, Logan Briggs, et al.
The New England Journal of Medicine|March 31, 2018
EPAS1 Mutations and Paragangliomas in Cyanotic Congenital Heart DiseaseAnand Vaidya, Shahida K Flores, Zi-Ming Cheng, et al.
Gynecologic Oncology|October 14, 2025
SMARCA4 pathogenic variants: Gynecological cancer histories from a laboratory tested cohortBrittany A Borden, Adela Rodriguez-Hernandez, Magan Trottier, et al.
JAMA Neurology|April 24, 2014
Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotesRoy N Alcalay, Tama Dinur, Timothy Quinn, et al.
JCO Oncology Practice|April 10, 2025
Video Education Is an Acceptable Alternative to Pretest Genetic Counseling for Patients With Breast, Ovarian, Pancreatic, and Metastatic Prostate Cancer: Results From a Randomized StudyKatherine A Schneider, Lauren Massingham, Michelle Weitz, et al.
British Journal of Cancer|December 24, 2021
CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancerElio Adib, Talal El Zarif, Amin H Nassar, et al.
Annals of Surgical Oncology|May 12, 2025
ASO Visual Abstract: Impact of the American Society of Breast Surgeons' Guidelines on Genetic Testing and Contralateral Prophylactic Mastectomy RatesAnna Weiss, Maria Sol Rosito, Danielle Braun, et al.
Annals of Surgical Oncology|March 20, 2025
Impact of the American Society of Breast Surgeons' Guidelines on Genetic Testing and Contralateral Prophylactic Mastectomy RatesAnna Weiss, Maria Sol Rosito, Danielle Braun, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Cancer Prevention Research (Philadelphia, Pa.)|April 19, 2024
Germline and Somatic Fumarate Hydratase Testing in Atypical Uterine LeiomyomataLindsay M Kipnis, Katelyn M Breen, Diane R Koeller, et al.
The American Journal of Case Reports|December 28, 2020
Unexpected Pathogenic RET p.V804M Variant Leads to the Clinical Diagnosis and Management of Medullary Thyroid CarcinomaArezou A Ghazani, Katelyn M Breen, Meaghan Dwan, et al.
Preventive Medicine|November 15, 2023
Racial differences in knowledge, attitudes, and sources of information about germline cancer genetic testing in the U.S.A.: An analysis of the health information National Trends Survey SystemKhalid Y Alkhatib, Dejan K Filipas, Logan Briggs, et al.
The New England Journal of Medicine|March 31, 2018
EPAS1 Mutations and Paragangliomas in Cyanotic Congenital Heart DiseaseAnand Vaidya, Shahida K Flores, Zi-Ming Cheng, et al.
Gynecologic Oncology|October 14, 2025
SMARCA4 pathogenic variants: Gynecological cancer histories from a laboratory tested cohortBrittany A Borden, Adela Rodriguez-Hernandez, Magan Trottier, et al.
JAMA Neurology|April 24, 2014
Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotesRoy N Alcalay, Tama Dinur, Timothy Quinn, et al.
JCO Oncology Practice|April 10, 2025
Video Education Is an Acceptable Alternative to Pretest Genetic Counseling for Patients With Breast, Ovarian, Pancreatic, and Metastatic Prostate Cancer: Results From a Randomized StudyKatherine A Schneider, Lauren Massingham, Michelle Weitz, et al.
British Journal of Cancer|December 24, 2021
CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancerElio Adib, Talal El Zarif, Amin H Nassar, et al.
Annals of Surgical Oncology|May 12, 2025
ASO Visual Abstract: Impact of the American Society of Breast Surgeons' Guidelines on Genetic Testing and Contralateral Prophylactic Mastectomy RatesAnna Weiss, Maria Sol Rosito, Danielle Braun, et al.
Annals of Surgical Oncology|March 20, 2025
Impact of the American Society of Breast Surgeons' Guidelines on Genetic Testing and Contralateral Prophylactic Mastectomy RatesAnna Weiss, Maria Sol Rosito, Danielle Braun, et al.
Pageof 8